PDS Biotech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23.09.2022 - FLORHAM PARK, N.J., Sept. 23, 2022 (GLOBE NEWSWIRE) - PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced ... Seite 1
Source: wallstreet-online.de